Brain Sciences (Feb 2021)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis

  • Tiziana Colletti,
  • Luisa Agnello,
  • Rossella Spataro,
  • Lavinia Guccione,
  • Antonietta Notaro,
  • Bruna Lo Sasso,
  • Valeria Blandino,
  • Fabiola Graziano,
  • Caterina Maria Gambino,
  • Rosaria Vincenza Giglio,
  • Giulia Bivona,
  • Vincenzo La Bella,
  • Marcello Ciaccio,
  • Tommaso Piccoli

DOI
https://doi.org/10.3390/brainsci11030302
Journal volume & issue
Vol. 11, no. 3
p. 302

Abstract

Read online

The involvement of β-amyloid (Aβ) in the pathogenesis of amyotrophic lateral sclerosis (ALS) has been widely discussed and its role in the disease is still a matter of debate. Aβ accumulates in the cortex and the anterior horn neurons of ALS patients and seems to affect their survival. To clarify the role of cerebrospinal fluid (CSF) Aβ 1–42 and Aβ 42/40 ratios as a potential prognostic biomarker for ALS, we performed a retrospective observational study on a cohort of ALS patients who underwent a lumbar puncture at the time of the diagnosis. CSF Aβ 1–40 and Aβ 1–42 ratios were detected by chemiluminescence immunoassay and their values were correlated with clinical features. We found a significant correlation of the Aβ 42/40 ratio with age at onset and Mini Mental State Examination (MMSE) scores. No significant correlation of Aβ 1–42 or Aβ 42/40 ratios to the rate of progression of the disease were found. Furthermore, when we stratified patients according to Aβ 1–42 concentration and the Aβ 42/40 ratio, we found that patients with a lower Aβ 42/40 ratio showed a shorter survival. Our results support the hypothesis that Aβ 1–42 could be involved in some pathogenic mechanism of ALS and we suggest the Aβ 42/40 ratio as a potential prognostic biomarker.

Keywords